Is NVMI or MIR more profitable?

Nova has a net margin of 29.21% compared to Mirion Technologies' net margin of 2.56%. Nova's return on equity of 21.77% beat Mirion Technologies' return on equity. Company Net Margins Return on Equity Return on Assets Nova 29.21% 21.77% 12.56% Mirion Technologies 2.56% 6.44% 3.48%

Does the media refer more to NVMI or MIR?

In the previous week, Nova had 7 more articles in the media than Mirion Technologies. MarketBeat recorded 13 mentions for Nova and 6 mentions for Mirion Technologies. Mirion Technologies' average media sentiment score of 1.12 beat Nova's score of 0.95 indicating that Mirion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nova 5 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mirion Technologies 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MIR or RVTY?

In the previous week, Revvity had 4 more articles in the media than Mirion Technologies. MarketBeat recorded 10 mentions for Revvity and 6 mentions for Mirion Technologies. Mirion Technologies' average media sentiment score of 1.12 beat Revvity's score of 0.08 indicating that Mirion Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mirion Technologies 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revvity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MIR or RAL?

In the previous week, Mirion Technologies had 3 more articles in the media than Ralliant. MarketBeat recorded 6 mentions for Mirion Technologies and 3 mentions for Ralliant. Mirion Technologies' average media sentiment score of 1.12 beat Ralliant's score of 1.01 indicating that Mirion Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mirion Technologies 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ralliant 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend BIO.B or MIR?

Mirion Technologies has a consensus target price of $27.13, indicating a potential upside of 60.60%. Given Mirion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Mirion Technologies is more favorable than Bio-Rad Laboratories. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Mirion Technologies 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.80

Does the media refer more to CAMT or MIR?

In the previous week, Mirion Technologies had 3 more articles in the media than Camtek. MarketBeat recorded 6 mentions for Mirion Technologies and 3 mentions for Camtek. Mirion Technologies' average media sentiment score of 1.12 beat Camtek's score of 0.33 indicating that Mirion Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Camtek 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mirion Technologies 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Mirion Technologies (MIR) Competitors

$16.89 -0.49 (-2.82%)

Closing price 03:59 PM Eastern

Extended Trading

$16.98 +0.09 (+0.56%)

As of 07:10 PM Eastern

Compare

MIR vs. NVMI, RVTY, RAL, BIO.B, and CAMT

Should you buy Mirion Technologies stock or one of its competitors? MarketBeat compares Mirion Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Mirion Technologies include Nova (NVMI), Revvity (RVTY), Ralliant (RAL), Bio-Rad Laboratories (BIO.B), and Camtek (CAMT). These companies are all part of the "measuring and control equipment" industry.

How does Mirion Technologies compare to Nova?

Nova (NASDAQ:NVMI) and Mirion Technologies (NYSE:MIR) are both measuring and control equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

Nova currently has a consensus price target of $551.25, suggesting a potential upside of 18.13%. Mirion Technologies has a consensus price target of $27.13, suggesting a potential upside of 60.60%. Given Mirion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Mirion Technologies is more favorable than Nova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nova	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

Nova has higher earnings, but lower revenue than Mirion Technologies. Nova is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nova	$902.53M	16.43	$259.22M	$8.02	58.18
Mirion Technologies	$981M	4.31	$28.80M	$0.10	168.90

In the previous week, Nova had 7 more articles in the media than Mirion Technologies. MarketBeat recorded 13 mentions for Nova and 6 mentions for Mirion Technologies. Mirion Technologies' average media sentiment score of 1.12 beat Nova's score of 0.95 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nova	5 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mirion Technologies	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

83.0% of Nova shares are owned by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are owned by institutional investors. 1.0% of Nova shares are owned by company insiders. Comparatively, 6.3% of Mirion Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Nova has a beta of 1.74, indicating that its stock price is 74% more volatile than the broader market. Comparatively, Mirion Technologies has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market.

Nova has a net margin of 29.21% compared to Mirion Technologies' net margin of 2.56%. Nova's return on equity of 21.77% beat Mirion Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nova	29.21%	21.77%	12.56%
Mirion Technologies	2.56%	6.44%	3.48%

Summary

Nova beats Mirion Technologies on 9 of the 16 factors compared between the two stocks.

How does Mirion Technologies compare to Revvity?

Mirion Technologies (NYSE:MIR) and Revvity (NYSE:RVTY) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

Revvity has higher revenue and earnings than Mirion Technologies. Revvity is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mirion Technologies	$981M	4.31	$28.80M	$0.10	168.90
Revvity	$2.86B	4.41	$241.20M	$2.09	54.00

In the previous week, Revvity had 4 more articles in the media than Mirion Technologies. MarketBeat recorded 10 mentions for Revvity and 6 mentions for Mirion Technologies. Mirion Technologies' average media sentiment score of 1.12 beat Revvity's score of 0.08 indicating that Mirion Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mirion Technologies	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Revvity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Mirion Technologies currently has a consensus price target of $27.13, indicating a potential upside of 60.60%. Revvity has a consensus price target of $108.92, indicating a potential downside of 3.49%. Given Mirion Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Mirion Technologies is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Revvity	1 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.20

Mirion Technologies has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, Revvity has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market.

78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 86.7% of Revvity shares are held by institutional investors. 6.3% of Mirion Technologies shares are held by insiders. Comparatively, 0.9% of Revvity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Revvity has a net margin of 8.26% compared to Mirion Technologies' net margin of 2.56%. Revvity's return on equity of 8.00% beat Mirion Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mirion Technologies	2.56%	6.44%	3.48%
Revvity	8.26%	8.00%	4.83%

Summary

Revvity beats Mirion Technologies on 10 of the 17 factors compared between the two stocks.

How does Mirion Technologies compare to Ralliant?

Mirion Technologies (NYSE:MIR) and Ralliant (NYSE:RAL) are both mid-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Mirion Technologies presently has a consensus price target of $27.13, suggesting a potential upside of 60.60%. Ralliant has a consensus price target of $69.00, suggesting a potential downside of 0.40%. Given Mirion Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Mirion Technologies is more favorable than Ralliant.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Ralliant	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.67

Mirion Technologies has higher earnings, but lower revenue than Ralliant. Ralliant is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mirion Technologies	$981M	4.31	$28.80M	$0.10	168.90
Ralliant	$2.12B	3.66	-$1.22B	-$10.94	N/A

78.5% of Mirion Technologies shares are held by institutional investors. 6.3% of Mirion Technologies shares are held by insiders. Comparatively, 0.4% of Ralliant shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Mirion Technologies has a net margin of 2.56% compared to Ralliant's net margin of -58.55%. Ralliant's return on equity of 12.49% beat Mirion Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mirion Technologies	2.56%	6.44%	3.48%
Ralliant	-58.55%	12.49%	6.40%

In the previous week, Mirion Technologies had 3 more articles in the media than Ralliant. MarketBeat recorded 6 mentions for Mirion Technologies and 3 mentions for Ralliant. Mirion Technologies' average media sentiment score of 1.12 beat Ralliant's score of 1.01 indicating that Mirion Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mirion Technologies	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ralliant	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Mirion Technologies beats Ralliant on 11 of the 14 factors compared between the two stocks.

How does Mirion Technologies compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO.B) and Mirion Technologies (NYSE:MIR) are both mid-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

Mirion Technologies has a consensus target price of $27.13, indicating a potential upside of 60.60%. Given Mirion Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Mirion Technologies is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

Bio-Rad Laboratories has a net margin of 6.52% compared to Mirion Technologies' net margin of 2.56%. Mirion Technologies' return on equity of 6.44% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	6.52%	3.56%	2.49%
Mirion Technologies	2.56%	6.44%	3.48%

In the previous week, Mirion Technologies had 6 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 6 mentions for Mirion Technologies and 0 mentions for Bio-Rad Laboratories. Mirion Technologies' average media sentiment score of 1.12 beat Bio-Rad Laboratories' score of 0.00 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Bio-Rad Laboratories	Neutral
Mirion Technologies	Positive

Bio-Rad Laboratories has higher revenue and earnings than Mirion Technologies. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.58B	3.07	$759.90M	$6.07	48.85
Mirion Technologies	$981M	4.31	$28.80M	$0.10	168.90

Bio-Rad Laboratories has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market. Comparatively, Mirion Technologies has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market.

0.0% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are held by institutional investors. 28.4% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 6.3% of Mirion Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Mirion Technologies beats Bio-Rad Laboratories on 12 of the 17 factors compared between the two stocks.

How does Mirion Technologies compare to Camtek?

Camtek (NASDAQ:CAMT) and Mirion Technologies (NYSE:MIR) are both mid-cap measuring and control equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

In the previous week, Mirion Technologies had 3 more articles in the media than Camtek. MarketBeat recorded 6 mentions for Mirion Technologies and 3 mentions for Camtek. Mirion Technologies' average media sentiment score of 1.12 beat Camtek's score of 0.33 indicating that Mirion Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Camtek	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Mirion Technologies	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Camtek has higher earnings, but lower revenue than Mirion Technologies. Camtek is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Camtek	$496.07M	13.34	$50.72M	$0.87	163.03
Mirion Technologies	$981M	4.31	$28.80M	$0.10	168.90

Camtek currently has a consensus price target of $174.67, indicating a potential upside of 23.14%. Mirion Technologies has a consensus price target of $27.13, indicating a potential upside of 60.60%. Given Mirion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Mirion Technologies is more favorable than Camtek.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Camtek	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Mirion Technologies	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

41.9% of Camtek shares are owned by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are owned by institutional investors. 79.4% of Camtek shares are owned by company insiders. Comparatively, 6.3% of Mirion Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Camtek has a beta of 1.55, meaning that its stock price is 55% more volatile than the broader market. Comparatively, Mirion Technologies has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

Camtek has a net margin of 9.63% compared to Mirion Technologies' net margin of 2.56%. Camtek's return on equity of 22.26% beat Mirion Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Camtek	9.63%	22.26%	11.70%
Mirion Technologies	2.56%	6.44%	3.48%

Summary

Camtek and Mirion Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get Mirion Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MIR vs. The Competition

Export

Metric	Mirion Technologies	Technology Services Industry	Business Sector	NYSE Exchange
Market Cap	$4.23B	$4.21B	$6.92B	$23.62B
Dividend Yield	N/A	2.14%	3.12%	3.98%
P/E Ratio	168.90	38.02	30.02	31.58
Price / Sales	4.31	54.80	371.21	177.70
Price / Cash	16.05	37.33	23.45	18.69
Price / Book	2.05	4.50	5.86	4.83
Net Income	$28.80M	$31.97M	$203.88M	$1.07B
7 Day Performance	-3.05%	7.66%	4.00%	0.72%
1 Month Performance	-0.96%	3.36%	3.31%	3.64%
1 Year Performance	-17.00%	7.41%	19.63%	18.34%

Mirion Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MIR Mirion Technologies	4.3167 of 5 stars	$16.89 -2.8%	$27.13 +60.6%	-14.6%	$4.23B	$981M	168.90	3,281	Positive News
NVMI Nova	4.4819 of 5 stars	$530.84 +2.0%	$545.50 +2.8%	+65.1%	$16.82B	$902.53M	65.98	1,612	Analyst Forecast Insider Trade
RVTY Revvity	2.2941 of 5 stars	$111.10 -0.1%	$108.33 -2.5%	+12.1%	$12.39B	$2.86B	53.14	11,000	Analyst Forecast
RAL Ralliant	2.1774 of 5 stars	$73.38 +1.3%	$69.00 -6.0%	N/A	$8.20B	$2.07B	N/A	7,000
BIO.B Bio-Rad Laboratories	N/A	$296.49 flat	N/A	+18.6%	$7.93B	$2.59B	48.85	8,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MIR) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mirion Technologies (MIR) Competitors

MIR vs. NVMI, RVTY, RAL, BIO.B, and CAMT

How does Mirion Technologies compare to Nova?

Summary

How does Mirion Technologies compare to Revvity?

Summary

How does Mirion Technologies compare to Ralliant?

Summary

How does Mirion Technologies compare to Bio-Rad Laboratories?

Summary

How does Mirion Technologies compare to Camtek?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MIR vs. The Competition

Mirion Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mirion Technologies (MIR) Competitors

MIR vs. NVMI, RVTY, RAL, BIO.B, and CAMT

How does Mirion Technologies compare to Nova?

Do analysts prefer NVMI or MIR?

Which has higher valuation and earnings, NVMI or MIR?

Does the media refer more to NVMI or MIR?

Do institutionals and insiders hold more shares of NVMI or MIR?

Which has more risk and volatility, NVMI or MIR?

Is NVMI or MIR more profitable?

Summary

How does Mirion Technologies compare to Revvity?

Which has better earnings & valuation, MIR or RVTY?

Does the media refer more to MIR or RVTY?

Do analysts prefer MIR or RVTY?

Which has more volatility & risk, MIR or RVTY?

Do institutionals and insiders have more ownership in MIR or RVTY?

Is MIR or RVTY more profitable?

Summary

How does Mirion Technologies compare to Ralliant?

Do analysts prefer MIR or RAL?

Which has preferable earnings & valuation, MIR or RAL?

Do insiders & institutionals believe in MIR or RAL?

Is MIR or RAL more profitable?

Does the media refer more to MIR or RAL?

Summary

How does Mirion Technologies compare to Bio-Rad Laboratories?

Do analysts recommend BIO.B or MIR?

Is BIO.B or MIR more profitable?

Does the media favor BIO.B or MIR?

Which has better valuation and earnings, BIO.B or MIR?

Which has more risk and volatility, BIO.B or MIR?

Do institutionals and insiders believe in BIO.B or MIR?

Summary

How does Mirion Technologies compare to Camtek?

Does the media refer more to CAMT or MIR?

Which has preferable valuation and earnings, CAMT or MIR?

Do analysts rate CAMT or MIR?

Do insiders and institutionals believe in CAMT or MIR?

Which has more volatility & risk, CAMT or MIR?

Is CAMT or MIR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MIR vs. The Competition

Mirion Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools